Diagnosing Polypoidal Choroidal Vasculopathy Using Color Fundus Photography, Optical Coherence Tomography, and Optical Coherence Tomography Angiography
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To compare the diagnostic accuracy of differentiating polypoidal choroidal vasculopathy (PCV) from exudative age-related macular degeneration (AMD), using color fundus photography (CFP), optical coherence tomography (OCT), and swept-source OCT angiography (SS-OCTA) without using indocyanine green angiography (ICGA). Methods: Treatment-naive eyes with exudative AMD that underwent CFP, OCT, SS-OCTA, and ICGA imaging before treatment were identified. Images of each patient were categorized into two sets (set A, CFP + OCT; set B, CFP + SS-OCTA). In set B, both the en face and cross-sectional B scans were analyzed. Each set was reviewed by two graders, and it was determined whether the presumed diagnosis was PCV. Sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) for the diagnosis of PCV were assessed for each set by comparing diagnoses that included ICGA. The number of polypoidal lesions in each set was calculated and compared to ICGA. Results: A total of 94 eyes from 94 patients with AMD were included in the study, of which 66.0% were male, and the mean age was 71.8 ± 9.0 years. The PCV diagnosis rate using ICGA was 45.7%. The sensitivity was 0.88 for set A and 0.93 for set B, while the specificity was 0.94 for set A and 0.96 for set B. The AUC was 0.90 (95% confidence interval [CI], 0.83–0.97) for set A and 0.96 (95% CI, 0.90–1.00) for set B. Set A detected 1.28 ± 0.91 polypoidal lesions, while set B detected 1.47 ± 1.01; ICGA showed 1.51 ± 0.86. Conclusions: This study highlights that, without using ICGA, both CFP combined with OCT and CFP combined with SS-OCTA demonstrate high sensitivity, specificity, and AUC in diagnosing PCV. It is evident that SS-OCTA contributes to enhancing sensitivity, specificity, and AUC for PCV diagnosis.
Abstract
Purpose: To compare the diagnostic accuracy of differentiating polypoidal choroidal vasculopathy (PCV) from exudative age-related macular degeneration (AMD), using color fundus photography (CFP), optical coherence tomography (OCT), and swept-source OCT angiography (SS-OCTA) without using indocyanine green angiography (ICGA). Methods: Treatment-naive eyes with exudative AMD that underwent CFP, OCT, SS-OCTA, and ICGA imaging before treatment were identified. Images of each patient were categorized into two sets (set A, CFP + OCT; set B, CFP + SS-OCTA). In set B, both the en face and cross-sectional B scans were analyzed. Each set was reviewed by two graders, and it was determined whether the presumed diagnosis was PCV. Sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) for the diagnosis of PCV were assessed for each set by comparing diagnoses that included ICGA. The number of polypoidal lesions in each set was calculated and compared to ICGA. Results: A total of 94 eyes from 94 patients with AMD were included in the study, of which 66.0% were male, and the mean age was 71.8 ± 9.0 years. The PCV diagnosis rate using ICGA was 45.7%. The sensitivity was 0.88 for set A and 0.93 for set B, while the specificity was 0.94 for set A and 0.96 for set B. The AUC was 0.90 (95% confidence interval [CI], 0.83–0.97) for set A and 0.96 (95% CI, 0.90–1.00) for set B. Set A detected 1.28 ± 0.91 polypoidal lesions, while set B detected 1.47 ± 1.01; ICGA showed 1.51 ± 0.86. Conclusions: This study highlights that, without using ICGA, both CFP combined with OCT and CFP combined with SS-OCTA demonstrate high sensitivity, specificity, and AUC in diagnosing PCV. It is evident that SS-OCTA contributes to enhancing sensitivity, specificity, and AUC for PCV diagnosis.
참고문헌 (23)
- Laude A, "Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration : same or different disease?", Prog Retin Eye Res, 29, pp.19~29 (2010)
- Coscas G, "Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients : multicenter diagnosis with multimodal imaging", Am J Ophthalmol, 158, pp.309~318 (2014)
- Cheung CM, "Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management", Ophthalmology, 125, pp.708~724 (2018)
- Yang S, "Resistance to anti-VEGF therapy in neovascular age-related macular degeneration : a comprehensive review", Drug Des Devel Ther, 10, pp.1857~1867 (2016)
- Tranos P, "Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration", Drug Des Devel Ther, 7, pp.485~490 (2013)
- Cheung CM, "Polypoidal choroidal vasculopathy : consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup", Ophthalmology, 128, pp.443~452 (2021)
- De Salvo G, "Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy", Am J Ophthalmol, 158, pp.1228~1238 (2014)
- Sengupta S, "Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy", Am J Ophthalmol, 160, pp.203~204 (2015)
- Kokame GT, "En face spectral-domain optical coherence tomography for the diagnosis and evaluation of polypoidal choroidal vasculopathy", Ophthalmic Surg Lasers Imaging Retina, 47, pp.737~744 (2016)
- Chaikitmongkol V, "Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy", JAMA Ophthalmol, 137, pp.661~667 (2019)
- Kim K, "A comparison study of polypoidal choroidal vasculopathy imaged with indocyanine green angiography and swept-source optical coherence tomography angiography", Am J Ophthalmol, 217, pp.240~251 (2020)
- Tanaka K, "Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy", Br J Ophthalmol, 101, pp.51~55 (2017)
- Srour M, "Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy", Br J Ophthalmol, 100, pp.1489~1493 (2016)
- Wang M, "Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography", Invest Ophthalmol Vis Sci, 57, pp.OCT526~32 (2016)
- Koh AH, "Polypoidal choroidal vasculopathy : evidence-based guidelines for clinical diagnosis and treatment", Retina, 33, pp.686~716 (2013)
- Lim TH, "Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy : the EVEREST II randomized clinical trial", JAMA Ophthalmol, 138, pp.935~942 (2020)
- Tan CS, "EVEREST study report 2:imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy", Br J Ophthalmol, 99, pp.624~628 (2015)
- Bo Q, "Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography", JAMA Ophthalmol, 137, pp.642~650 (2019)
- Chi YT, "Optical coherence tomography angiography for assessment of the 3-dimensional structures of polypoidal choroidal vasculopathy", JAMA Ophthalmol, 135, pp.1310~1316 (2017)
- Young Suk Chang, "Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients", Korean Journal of Ophthalmology, 30(3), pp.198~205 (2016), 대한안과학회
- Chaikitmongkol V, "Color fundus photography, optical coherence tomography, and fluorescein angiography in diagnosing polypoidal choroidal vasculopathy", Am J Ophthalmol, 192, pp.77~83 (2018)
- Miller AR, "Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization", Invest Ophthalmol Vis Sci, 58, pp.1499~1505 (2017)
- Rebhun CB, "Polypoidal choroidal vasculopathy on swept-source optical coherence tomography angiography with variable interscan time analysis", Transl Vis Sci Technol, 6, pp.4~ (2017)